Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal

MLA

Takemasa Sakakuchi, et al. Inhibiting SARS-CoV-2 Infection in Vitro by Suppressing Its Receptor, Angiotensin-Converting Enzyme 2, via Aryl-Hydrocarbon Receptor Signal. Mar. 2021. EBSCOhost, https://doi.org/10.1101/2021.03.04.433658.

APA

Takemasa Sakakuchi, Keiji Tanimoto, Hidemasa Bono, Nazmul Tanuza, Toshihito Nomura, Yoshiyuki Matsuo, Kiichi Hirota, Nobuyuki Hirohashi, & Takahiro Fukazawa. (2021). Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal. https://doi.org/10.1101/2021.03.04.433658

Chicago

Takemasa Sakakuchi, Keiji Tanimoto, Hidemasa Bono, Nazmul Tanuza, Toshihito Nomura, Yoshiyuki Matsuo, Kiichi Hirota, Nobuyuki Hirohashi, and Takahiro Fukazawa. 2021. “Inhibiting SARS-CoV-2 Infection in Vitro by Suppressing Its Receptor, Angiotensin-Converting Enzyme 2, via Aryl-Hydrocarbon Receptor Signal,” March. doi:10.1101/2021.03.04.433658.